Locus IT Services Nordic’s Post

🫀🔍 New AI Tool Identifies Risk of Future Heart Failure 🌐💡 🧠 A Yale-led study developed an AI tool using ECG images to identify high-risk heart failure patients, enabling earlier intervention and potentially reducing hospitalizations and deaths. 📉 This tool enhances heart failure risk prediction by utilizing widely available ECG tests, offering a new approach to cardiovascular disease screening. 🌍 Validated across diverse populations, it highlights the potential for global adoption and equitable implementation in healthcare. For more details: https://lnkd.in/gA342PyX #ai #datascience #machinelearning #lifescience #HeartFailure #ECG #HealthcareInnovation #CardiovascularHealth #EarlyDetection #YaleResearch #GlobalHealth 

The Power of Early Diagnosis in Healthcare: Why It Matters ? As doctors, one of our most important roles is to identify and treat diseases as early as possible. Early diagnosis often means the difference between life and death, especially in cases of cancer, heart disease, and other chronic conditions. With advancements in healthcare technology, the way we diagnose diseases is evolving rapidly. AI-powered diagnostic tools are revolutionizing the speed and accuracy of early detection. These technologies can analyze vast amounts of medical data and provide insights that help doctors identify potential issues much sooner than traditional methods. Imagine the impact of detecting cancer at Stage 1 instead of Stage 3—it's a game-changer! By integrating AI and other cutting-edge technologies into our practice, we can not only save more lives but also enhance the quality of life for our patients. As someone passionate about healthcare innovation, I truly believe that early diagnosis powered by technology is the future. We are just scratching the surface of what’s possible. What are your thoughts on the role of technology in early diagnosis? Is it the future of healthcare, or are there challenges we need to overcome first? #EarlyDiagnosis #HealthcareInnovation #AIinMedicine #FutureOfHealthcare #DoctorLife

Did you know that early detection can save lives? If you have been following our posts, you will definitely know! At Previu, we believe in empowering individuals with knowledge about their health. That’s why we’re pioneering the use of genetics and AI to personalise healthcare like never before. Here’s how early detection works: Identify Risks: Advanced genetic tests reveal your susceptibility to conditions like cancer. Act Early: Spot warning signs before they turn into serious health issues. Live Confidently: Personalised insights help you take charge of your health. Why it matters: Research shows that 70% of cancer cases are more treatable when caught early. But many people wait for symptoms, which can delay diagnosis. Our solution: Through cutting-edge Next-Generation Sequencing (NGS) technology, we decode your genetic blueprint to provide actionable health insights. Whether it’s identifying cancer risks or improving your gut health, we’ve got you covered. Take the first step today: Your health is your wealth. Let’s prioritise it together. Share this post to spread awareness about the power of preventive care. #previu #previuhealth #aihealth #aihealthcare #EarlyDetection #preventivecare

When it comes to detecting and diagnosing lung diseases, 🫁 we can and must do better for patients. AI has the potential to enhance diagnostic accuracy, predict disease, and close critical care gaps—especially when thoughtfully integrated into provider workflows. 🩺 Steven Dalvin, MD, MBA, Director of Life Science Innovation at Viz.ai, shares his insights on the opportunities for AI and digital care coordination in lung diseases. 👉 Read more here: https://lnkd.in/g9inW-zp #AI #LungDisease #DigitalHealth #HealthcareInnovation #Vizai #LungCancer

Interesting findings from the latest real-world study in children with #CysticFibrosis Homozygous for F508del in the Netherlands, further reinforcing the impact of #AI-enabled lung image analysis in assessing and optimizing CF treatment strategies. Following in the footsteps of earlier studies, this new research provides compelling evidence that the CFTR modulators Ivacaftor/Lumacaftor improve lung structure - but also highlights the need for accurate and sensitive tools to monitor CF lung disease. With growing evidence that AI-powered CT analysis outperforms conventional lung function tests in monitoring structural lung changes, integrating these tools into clinical trials and real-world CF management should be a priority. Read the full publication: https://lnkd.in/eM5xKRb7 Want to learn more about how AI can support your clinical trials in CF and other lung diseases? Get in touch! #AI #MedicalImaging #Lungs #PrecisionMedicine #LungQ

❤️ Transforming Healthcare with AI: Heart Disease Prediction System 💡 I'm thrilled to introduce my latest project—an AI-powered Heart Disease Prediction System that takes healthcare diagnostics to a whole new level. This system leverages a wide range of medical data, including: -->Age, Sex, and Chest Pain Type: Vital demographic and symptom information. -->Resting Blood Pressure & Cholesterol Levels: Essential cardiovascular health markers. -->Fasting Blood Sugar & ECG Results: Insight into metabolic and heart function. -->Maximum Heart Rate & Exercise-Induced Angina: Stress test responses. -->Oldpeak & ST Segment Slope: Indicators of exercise-induced heart strain. -->Major Vessels and Thalassemia Conditions: Vascular health and genetic factors. What sets this system apart? It combines these diverse metrics to deliver remarkably accurate predictions of heart disease, offering early detection and personalized insights. This isn’t just another diagnostic tool—it’s a leap towards personalized, data-driven healthcare that can empower both patients and doctors with early, accurate insights. Github URL:-https://lnkd.in/emnBveEd #AI #HeartDiseasePrediction #MachineLearning #HealthTech #DataScience #HealthcareInnovation #PrecisionMedicine #LifeSavingTech

Exact Sciences recently shared new modeling #data describing the projected impact of the Cologuard test on patients, #healthcare professionals, and the U.S. health care system since its FDA approval 10 years ago. The data assessed the far-reaching benefits of the first and only multi-target stool DNA test for patients, their families, and the health care system. Over the past 10 years, the Cologuard test has been used to screen for colorectal #cancer more than 16 million times. Press Release: 'New modeling data show the Cologuard test has detected more than 623,000 cancers and precancers over past decade, saving U.S. health care system $22 billion' https://lnkd.in/gVJ68a6F #Wisconsin #innovation

Despite advancements in medical science, numerous challenges remain such as: Rare Disease Diagnosis Cancer Detection and Treatment Personalization Antibiotic Resistance Mental Health Disorders Access to Healthcare Drug Discovery and Development How can #AI help add value in these critical areas of medicine? https://bit.ly/41IFgDh

Today on #WorldLiverDay, we acknowledge the vital role the liver plays in maintaining our health and well-being. As we focus on #LiverHealth, advancements in analytical technologies contribute significantly to our understanding and ability to diagnose liver-related conditions. At #Shimadzu, we're committed to advancing liver health research, and one of the tools utilised is Liquid Chromatograph Mass Spectrometry #LCMSMS. This cutting-edge technology allows us to precisely analyze #BileAcids, and crucial biomarkers for liver function assessment and disease diagnosis. 💡Explore how our 𝙇𝘾-𝙈𝙎/𝙈𝙎 𝙈𝙚𝙩𝙝𝙤𝙙 𝙋𝙖𝙘𝙠𝙖𝙜𝙚 𝙛𝙤𝙧 𝘽𝙞𝙡𝙚 𝘼𝙘𝙞𝙙𝙨 boosts liver health research and clinical diagnostics 🔗 https://lnkd.in/dJxM4nAG Together, let's continue to innovate and raise awareness about Liver Health to ensure healthier lives for all 🛡️